Fulgent Historical Balance Sheet

FLGT Stock

USD 20.24 0.11 0.55%

Trend analysis of Fulgent Genetics balance sheet accounts such as Total Current Liabilities of 49.4 M or Total Stockholder Equity of 1.2 B provides information on Fulgent Genetics' total assets, liabilities, and equity, which is the actual value of Fulgent Genetics to its prevalent stockholders. By breaking down trends over time using Fulgent Genetics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Fulgent Genetics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fulgent Genetics is a good buy for the upcoming year.

Fulgent Genetics Inventory

4.43 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.

About Fulgent Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Fulgent Genetics at a specified time, usually calculated after every quarter, six months, or one year. Fulgent Genetics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Fulgent Genetics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Fulgent currently owns. An asset can also be divided into two categories, current and non-current.

Fulgent Genetics Balance Sheet Chart

At this time, Fulgent Genetics' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Other Current Assets is likely to gain to about 27.6 M in 2024, whereas Accounts Payable is likely to drop slightly above 10.3 M in 2024.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Non Currrent Assets Other Long Term Debt

Add Fundamental

Total Assets

Total assets refers to the total amount of Fulgent Genetics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Fulgent Genetics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Fulgent Genetics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Fulgent Genetics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Long Term Debt

Long-term debt is a debt that Fulgent Genetics has held for over one year. Long-term debt appears on Fulgent Genetics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Fulgent Genetics balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most accounts from Fulgent Genetics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Fulgent Genetics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.At this time, Fulgent Genetics' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Other Current Assets is likely to gain to about 27.6 M in 2024, whereas Accounts Payable is likely to drop slightly above 10.3 M in 2024.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	28.4M	24.2M	26.9M	28.3M
Total Assets	1.3B	1.4B	1.2B	1.3B

Other Current Liab Total Assets

Fulgent Genetics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Property Plant Equipment	Common Stock Total Equity	Common Stock	Other Liab
Total Assets		0.92	0.86	1.0	0.99	0.97	-0.91	0.98	0.85	0.87	0.87	-0.18	0.43	0.9	0.64	0.93	0.67	0.84	0.92	0.88	0.97	0.9	0.96	-0.59	-0.59	0.8
Other Current Liab	0.92		0.94	0.9	0.92	0.88	-0.91	0.84	0.94	0.89	0.73	-0.15	0.4	0.84	0.87	0.88	0.88	0.66	0.92	0.95	0.84	0.88	0.85	-0.6	-0.6	0.63
Total Current Liabilities	0.86	0.94		0.84	0.83	0.76	-0.87	0.78	1.0	0.91	0.55	-0.31	0.48	0.92	0.9	0.88	0.9	0.61	0.93	0.99	0.72	0.95	0.72	-0.56	-0.56	0.47
Total Stockholder Equity	1.0	0.9	0.84		0.99	0.98	-0.9	0.99	0.84	0.86	0.88	-0.18	0.43	0.89	0.62	0.93	0.64	0.85	0.91	0.87	0.97	0.89	0.96	-0.59	-0.59	0.81
Net Tangible Assets	0.99	0.92	0.83	0.99		0.97	-0.93	0.97	0.82	0.88	0.88	-0.06	0.47	0.87	0.65	0.92	0.68	0.79	0.9	0.86	0.96	0.87	0.96	-0.6	-0.6	0.79
Property Plant And Equipment Net	0.97	0.88	0.76	0.98	0.97		-0.83	0.96	0.77	0.77	0.96	-0.16	0.27	0.78	0.54	0.87	0.57	0.87	0.86	0.81	1.0	0.78	1.0	-0.59	-0.59	0.9
Net Debt	-0.91	-0.91	-0.87	-0.9	-0.93	-0.83		-0.85	-0.85	-0.98	-0.66	-0.13	-0.72	-0.9	-0.81	-0.89	-0.83	-0.53	-0.9	-0.88	-0.79	-0.92	-0.79	0.58	0.58	-0.51
Retained Earnings	0.98	0.84	0.78	0.99	0.97	0.96	-0.85		0.77	0.82	0.88	-0.2	0.42	0.88	0.52	0.88	0.55	0.88	0.85	0.81	0.96	0.86	0.95	-0.48	-0.48	0.83
Accounts Payable	0.85	0.94	1.0	0.84	0.82	0.77	-0.85	0.77		0.89	0.56	-0.34	0.43	0.9	0.89	0.89	0.9	0.63	0.94	0.99	0.73	0.93	0.73	-0.6	-0.6	0.49
Cash	0.87	0.89	0.91	0.86	0.88	0.77	-0.98	0.82	0.89		0.57	0.05	0.74	0.94	0.83	0.91	0.85	0.51	0.93	0.92	0.74	0.96	0.72	-0.57	-0.57	0.43
Non Current Assets Total	0.87	0.73	0.55	0.88	0.88	0.96	-0.66	0.88	0.56	0.57		-0.14	0.06	0.58	0.31	0.73	0.34	0.87	0.69	0.62	0.97	0.57	0.97	-0.47	-0.47	0.98
Non Currrent Assets Other	-0.18	-0.15	-0.31	-0.18	-0.06	-0.16	-0.13	-0.2	-0.34	0.05	-0.14		0.46	-0.23	-0.03	-0.21	-0.01	-0.55	-0.22	-0.28	-0.2	-0.2	-0.2	0.14	0.14	-0.31
Other Assets	0.43	0.4	0.48	0.43	0.47	0.27	-0.72	0.42	0.43	0.74	0.06	0.46		0.66	0.53	0.49	0.54	-0.01	0.47	0.45	0.24	0.66	0.21	-0.24	-0.24	-0.11
Cash And Short Term Investments	0.9	0.84	0.92	0.89	0.87	0.78	-0.9	0.88	0.9	0.94	0.58	-0.23	0.66		0.72	0.92	0.74	0.68	0.92	0.91	0.77	0.99	0.74	-0.56	-0.56	0.5
Net Receivables	0.64	0.87	0.9	0.62	0.65	0.54	-0.81	0.52	0.89	0.83	0.31	-0.03	0.53	0.72		0.68	1.0	0.25	0.77	0.87	0.48	0.79	0.49	-0.49	-0.49	0.17
Common Stock Shares Outstanding	0.93	0.88	0.88	0.93	0.92	0.87	-0.89	0.88	0.89	0.91	0.73	-0.21	0.49	0.92	0.68		0.7	0.74	0.99	0.91	0.86	0.93	0.85	-0.78	-0.78	0.65
Inventory	0.67	0.88	0.9	0.64	0.68	0.57	-0.83	0.55	0.9	0.85	0.34	-0.01	0.54	0.74	1.0	0.7		0.27	0.79	0.89	0.5	0.8	0.52	-0.48	-0.48	0.2
Other Current Assets	0.84	0.66	0.61	0.85	0.79	0.87	-0.53	0.88	0.63	0.51	0.87	-0.55	-0.01	0.68	0.25	0.74	0.27		0.7	0.65	0.9	0.64	0.9	-0.45	-0.45	0.93
Other Stockholder Equity	0.92	0.92	0.93	0.91	0.9	0.86	-0.9	0.85	0.94	0.93	0.69	-0.22	0.47	0.92	0.77	0.99	0.79	0.7		0.96	0.83	0.93	0.83	-0.74	-0.74	0.61
Total Liab	0.88	0.95	0.99	0.87	0.86	0.81	-0.88	0.81	0.99	0.92	0.62	-0.28	0.45	0.91	0.87	0.91	0.89	0.65	0.96		0.77	0.94	0.77	-0.57	-0.57	0.54
Property Plant And Equipment Gross	0.97	0.84	0.72	0.97	0.96	1.0	-0.79	0.96	0.73	0.74	0.97	-0.2	0.24	0.77	0.48	0.86	0.5	0.9	0.83	0.77		0.76	1.0	-0.56	-0.56	0.93
Total Current Assets	0.9	0.88	0.95	0.89	0.87	0.78	-0.92	0.86	0.93	0.96	0.57	-0.2	0.66	0.99	0.79	0.93	0.8	0.64	0.93	0.94	0.76		0.74	-0.57	-0.57	0.48
Property Plant Equipment	0.96	0.85	0.72	0.96	0.96	1.0	-0.79	0.95	0.73	0.72	0.97	-0.2	0.21	0.74	0.49	0.85	0.52	0.9	0.83	0.77	1.0	0.74		-0.57	-0.57	0.93
Common Stock Total Equity	-0.59	-0.6	-0.56	-0.59	-0.6	-0.59	0.58	-0.48	-0.6	-0.57	-0.47	0.14	-0.24	-0.56	-0.49	-0.78	-0.48	-0.45	-0.74	-0.57	-0.56	-0.57	-0.57		1.0	-0.41
Common Stock	-0.59	-0.6	-0.56	-0.59	-0.6	-0.59	0.58	-0.48	-0.6	-0.57	-0.47	0.14	-0.24	-0.56	-0.49	-0.78	-0.48	-0.45	-0.74	-0.57	-0.56	-0.57	-0.57	1.0		-0.41
Other Liab	0.8	0.63	0.47	0.81	0.79	0.9	-0.51	0.83	0.49	0.43	0.98	-0.31	-0.11	0.5	0.17	0.65	0.2	0.93	0.61	0.54	0.93	0.48	0.93	-0.41	-0.41

Click cells to compare fundamentals

Fulgent Genetics Account Relationship Matchups

Fulgent Genetics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	88.8M	700.5M	1.3B	1.4B	1.2B	1.3B
Other Current Liab	3.6M	35.0M	28.4M	24.2M	26.9M	28.3M
Total Current Liabilities	6.0M	131.1M	112.8M	116.2M	73.0M	49.4M
Total Stockholder Equity	82.8M	569.4M	1.2B	1.3B	1.1B	1.2B
Net Tangible Assets	82.8M	569.4M	1.2B	973.0M	1.1B	1.2B
Property Plant And Equipment Net	6.0M	40.2M	62.3M	81.4M	95.6M	100.4M
Net Debt	(9.3M)	(71.6M)	(143.6M)	(58.9M)	(82.2M)	(78.1M)
Retained Earnings	(63.4M)	150.9M	657.6M	801M	633.2M	664.8M
Accounts Payable	1.6M	26.5M	20.5M	23.1M	15.4M	10.3M
Cash	12.0M	87.4M	164.9M	79.5M	97.5M	50.9M
Non Current Assets Total	12.0M	84.7M	204.3M	480.4M	727.5M	763.9M
Non Currrent Assets Other	(36.8M)	(88.0M)	142.0M	(287.4M)	22.7M	23.9M
Other Assets	251K	44.5M	912.6M	26.6M	1.0	0.95
Cash And Short Term Investments	70.2M	431.9M	935.5M	852.9M	424.2M	312.5M
Net Receivables	6.6M	204.1M	143.3M	52.7M	57.4M	52.9M
Common Stock Shares Outstanding	18.7M	24.1M	31.0M	31.0M	29.8M	23.5M
Liabilities And Stockholders Equity	88.8M	700.5M	1.3B	1.4B	1.2B	1.3B
Inventory	277K	16.5M	12.2M	4.3M	5.8M	4.4M
Other Current Assets	277K	3.7M	6.0M	44.5M	26.2M	27.6M
Other Stockholder Equity	146.1M	418.1M	501.9M	486.6M	501.7M	263.1M
Total Liab	6.0M	131.1M	112.8M	116.2M	102.0M	52.6M
Property Plant And Equipment Gross	8.6M	41.0M	81.9M	124.6M	135.1M	141.9M
Total Current Assets	76.8M	615.7M	1.1B	905.6M	507.8M	365.6M
Accumulated Other Comprehensive Income	146K	438K	(759K)	(20.9M)	1.2M	1.3M
Property Plant Equipment	8.6M	40.2M	62.3M	98.9M	113.8M	119.4M
Retained Earnings Total Equity	(63.0M)	(63.4M)	150.9M	657.6M	756.2M	794.0M
Short Term Investments	58.3M	344.4M	770.7M	773.4M	326.7M	326.9M
Non Current Liabilities Total	2.3M	959K	7.5M	28.1M	29.0M	30.5M
Capital Surpluse	114.2M	146.1M	418.1M	501.9M	577.2M	606.1M
Long Term Investments	42.8M	132.5M	507.0M	339.0M	444.0M	466.2M
Non Current Liabilities Other	2.3M	959K	7.5M	28.1M	11.0M	6.8M
Net Invested Capital	82.8M	584.4M	1.2B	1.3B	1.1B	688.3M
Net Working Capital	33.4M	393.5M	961.6M	539.8M	434.8M	381.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Fulgent Stock Analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Fulgent Historical Balance Sheet

Fulgent Genetics Inventory

4.43 Million

About Fulgent Balance Sheet Analysis

Fulgent Genetics Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Non Currrent Assets Other

Long Term Debt

Fulgent Genetics balance sheet Correlations

Fulgent Genetics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Fulgent Genetics balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Fulgent Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant Equipment	+ 1.0	Property Plant And Equipment Net
Inventory	+ 1.0	Net Receivables
Property Plant Equipment	+ 1.0	Property Plant And Equipment Gross

Cash	- 0.98	Net Debt
Net Debt	- 0.93	Net Tangible Assets
Total Current Assets	- 0.92	Net Debt
Net Debt	- 0.91	Other Current Liab
Net Debt	- 0.91	Total Assets
Other Stockholder Equity	- 0.9	Net Debt